Patents by Inventor Fritz Ott

Fritz Ott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cell-mediated immune diseases
    Patent number: 8541469
    Abstract: 9-cis retinoic acid and pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, 9-cis retinal and pharmaceutically acceptable acetals thereof, and 9-cis retinol and pharmaceutically acceptable hydrolyzable esters thereof as well as metabolites of 9-cis retinoic acid have been found to be efficacious in treating T-helper cell type 1 mediated immune diseases in well tolerated doses. Preferably, the active ingredient is formulated as a medicament for oral or topical administration.
    Type: Grant
    Filed: May 12, 2006
    Date of Patent: September 24, 2013
    Assignee: Glaxo Group Limited
    Inventors: Werner Bollag, Fritz Ott
  • Treatment of cell-mediated immune diseases
    Publication number: 20060264504
    Abstract: 9-cis retinoic acid and pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, 9-cis retinal and pharmaceutically acceptable acetals thereof, and 9-cis retinol and pharmaceutically acceptable hydrolyzable esters thereof as well as metabolites of 9-cis retinoic acid have been found to be efficacious in treating T-helper cell type 1 mediated immune diseases in well tolerated doses. Preferably, the active ingredient is formulated as a medicament for oral or topical administration.
    Type: Application
    Filed: May 12, 2006
    Publication date: November 23, 2006
    Inventors: Werner Bollag, Fritz Ott
  • Treatment of cell-mediated immune diseases
    Publication number: 20040039056
    Abstract: The present invention relates to the use of 9-cis retinoic acid and derivatives or precursors thereof for the manufacture of a medicament for the treatment of T-helper cell type 1 mediated immune disease as well as to the use of said active substances for the treatment of such diseases, which diseases are eczematoid conditions in a human patient.
    Type: Application
    Filed: June 11, 2003
    Publication date: February 26, 2004
    Inventors: Werner Bollag, Fritz Ott
  • Treatment of cell-mediated immune diseases
    Patent number: 6589989
    Abstract: The invention is related to a method of treating chronic hand eczema in a human patient in need of treatment, using oral administration of 9-cis retinoic acid and pharmaceutically acceptable salts and pharmaceutically acceptable hydrolysable esters thereof, in an effective amount of from 0.05 to 1.5 milligrams per kilogram body weight per day.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: July 8, 2003
    Assignee: Basilea Pharmaceutica AG
    Inventors: Werner Bollag, Fritz Ott